PLoS ONE (Jan 2024)

Data quality assessment of the Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), Thailand, 2015-2021.

  • Jaray Tongtoyai,
  • Thitima Cherdtrakulkiat,
  • Natnaree Girdthep,
  • Silvina Masciotra,
  • Santi Winaitham,
  • Pongsathorn Sangprasert,
  • Ekkachai Daengsaard,
  • Anuparp Puangsoi,
  • Rossaphorn Kittiyaowamarn,
  • Eileen F Dunne,
  • Pachara Sirivongrangson,
  • Andrew C Hickey,
  • Emily Weston,
  • Rebekah M Frankson

DOI
https://doi.org/10.1371/journal.pone.0305296
Journal volume & issue
Vol. 19, no. 7
p. e0305296

Abstract

Read online

BackgroundQuality assessments of gonococcal surveillance data are critical to improve data validity and to enhance the value of surveillance findings. Detecting data errors by systematic audits identifies areas for quality improvement. We designed and implemented an internal audit process to evaluate the accuracy and completeness of surveillance data for the Thailand Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP).MethodsWe conducted a data quality audit of source records by comparison with the data stored in the EGASP database for five audit cycles from 2015-2021. Ten percent of culture-confirmed cases of Neisseria gonorrhoeae were randomly sampled along with any cases identified with elevated antimicrobial susceptibility testing results and cases with repeat infections. Incorrect and incomplete data were investigated, and corrective action and preventive actions (CAPA) were implemented. Accuracy was defined as the percentage of identical data in both the source records and the database. Completeness was defined as the percentage of non-missing data from either the source document or the database. Statistical analyses were performed using the t-test and the Fisher's exact test.ResultsWe sampled and reviewed 70, 162, 85, 68, and 46 EGASP records during the five audit cycles. Overall accuracy and completeness in the five audit cycles ranged from 93.6% to 99.4% and 95.0% to 99.9%, respectively. Overall, completeness was significantly higher than accuracy (p = 0.017). For each laboratory and clinical data element, concordance was >85% in all audit cycles except for two laboratory data elements in two audit cycles. These elements significantly improved following identification and CAPA implementation.DiscussionWe found a high level of data accuracy and completeness in the five audit cycles. The implementation of the audit process identified areas for improvement. Systematic quality assessments of laboratory and clinical data ensure high quality EGASP surveillance data to monitor for antimicrobial resistant Neisseria gonorrhoeae in Thailand.